Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1371621000168114 | Lignocaine Hydrochloride (Pfizer (Perth)) (lignocaine hydrochloride anhydrous 50 mg / 5 mL) injection: solution, 10 x 5 mL ampoules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1371631000168112 | Lignocaine Hydrochloride (Pfizer (Perth)) 1% (50 mg/5 mL) injection: solution, 10 x 5 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lignocaine Hydrochloride (Pfizer (Perth)) 1% (50 mg/5 mL) injection: solution, 10 x 5 mL ampoules | Is a | trade product pack | false | Inferred relationship | Some | ||
| Lignocaine Hydrochloride (Pfizer (Perth)) 1% (50 mg/5 mL) injection: solution, 10 x 5 mL ampoules | Is a | lidocaine hydrochloride 1% (50 mg/5 mL) injection, 10 x 5 mL ampoules | false | Inferred relationship | Some | ||
| Lignocaine Hydrochloride (Pfizer (Perth)) 1% (50 mg/5 mL) injection: solution, 10 x 5 mL ampoules | has TPUU | Lignocaine Hydrochloride (Pfizer (Perth)) 1% (50 mg/5 mL) injection: solution, 5 mL ampoule | false | Inferred relationship | Some | ||
| Lignocaine Hydrochloride (Pfizer (Perth)) 1% (50 mg/5 mL) injection: solution, 10 x 5 mL ampoules | has TP | Lignocaine Hydrochloride (Pfizer (Perth)) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lignocaine Hydrochloride (Pfizer (Perth)) 1% (50 mg/5 mL) injection: solution, 10 x 5 mL ampoules | Is a | False | Lignocaine Hydrochloride (Pfizer (Perth)) 1% (50 mg/5 mL) injection: solution, 10 x 5 mL ampoules | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR